|
ARHGAP29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.401700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.695220E-01 |
| Normal-vs-Stage2 |
2.379400E-01 |
| Normal-vs-Stage3 |
3.235000E-01 |
| Normal-vs-Stage4 |
5.269000E-01 |
| Stage1-vs-Stage2 |
6.790600E-01 |
| Stage1-vs-Stage3 |
7.687000E-01 |
| Stage1-vs-Stage4 |
9.826800E-01 |
| Stage2-vs-Stage3 |
9.035200E-01 |
| Stage2-vs-Stage4 |
7.781400E-01 |
| Stage3-vs-Stage4 |
8.792200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.030400E-02 |
| Normal-vs-AfricanAmerican |
2.260800E-01 |
| Normal-vs-Asian |
1.979180E-01 |
| Caucasian-vs-AfricanAmerican |
7.412000E-01 |
| Caucasian-vs-Asian |
3.143000E-01 |
| AfricanAmerican-vs-Asian |
2.420200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.273800E-01 |
| Normal-vs-Female |
4.575600E-03 |
| Male-vs-Female |
1.867800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.518800E-01 |
| Normal-vs-Extreme_Weight |
2.900600E-01 |
| Normal-vs-Obese |
6.956400E-02 |
| Normal-vs-Extreme_Obese |
9.203000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.737200E-01 |
| Normal_Weight-vs-Obese |
6.817000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.148800E-01 |
| Extreme_Weight-vs-Obese |
4.253000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.158800E-01 |
| Obese-vs-Extreme_Obese |
3.797600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.453830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.024100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.823800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.670100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.616800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.371010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.339800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.060400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.034500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.422180E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.981900E-03 |
| Normal-VS-Type2 PRCC |
1.114450E-01 |
| Normal-VS-KIRP CIMP |
6.143900E-02 |
| Normal-VS-Unclassified PRCC |
8.224300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.011130E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.358000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.465000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.212100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.080800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.779200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.848400E-01 |
| Normal-vs-N1 |
6.806100E-02 |
| Normal-vs-N2 |
8.319400E-01 |
| N0-vs-N1 |
2.650300E-02 |
| N0-vs-N2 |
4.492400E-01 |
| N1-vs-N2 |
5.463000E-01 |
|
|
